Smokers in south asia get a new ally: pharmacists with graphic warning booklets

NCT ID NCT07098065

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether showing smokers graphic health warnings (like pictures of diseased lungs) along with personalized advice from a pharmacist can help them quit. About 3,400 adult smokers in Bangladesh and Pakistan will be split into three groups: one gets only the warning booklets, another gets booklets plus counseling and SMS reminders, and a third gets usual pharmacy care. The main goal is to see how many people stop smoking for at least a week after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
graphic health warnings and pharmacist-led counseling
What this could lead to
If successful, this could provide a low-cost, scalable way to help smokers quit and reduce chronic diseases like heart disease and diabetes in resource-limited settings.
What could go wrong
This is a behavioral intervention, not a drug, so results depend on participant motivation and follow-up. The trial is still recruiting, and the primary outcome is self-reported, which may be less reliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTH WARNING LABEL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder Noncommunicable Diseases Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Global Public Health Research Foundation

    RECRUITING

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.